353 related articles for article (PubMed ID: 1323922)
1. The murine autoimmune diabetes model: NOD and related strains.
Kikutani H; Makino S
Adv Immunol; 1992; 51():285-322. PubMed ID: 1323922
[No Abstract] [Full Text] [Related]
2. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
3. Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW; Jun HS
Ann N Y Acad Sci; 2001 Apr; 928():200-11. PubMed ID: 11795511
[TBL] [Abstract][Full Text] [Related]
4. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
Schmidt D; Verdaguer J; Averill N; Santamaria P
J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune diabetes-prone NOD mice express the Lyt2 alpha (Lyt2.1) and Lyt3 alpha (Lyt3.1) alleles of CD8.
Johnson-Tardieu JM; Walworth EW; Cornelius JG; Ye X; Schuster SM; Peck AB
Immunogenetics; 1996; 43(1-2):6-12. PubMed ID: 8537123
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analyses comparing all major spleen cell phenotypes in BB and normal rats: autoimmune imbalance and double negative T cells associated with resistant, prone and diabetic animals.
Hosszufalusi N; Chan E; Granger G; Charles MA
J Autoimmun; 1992 Jun; 5(3):305-18. PubMed ID: 1388637
[TBL] [Abstract][Full Text] [Related]
7. Reduction in diabetes incidence in an I-Ag7 transgenic nonobese diabetic mouse line.
Wherrett DK; Singer SM; McDevitt HO
Diabetes; 1997 Dec; 46(12):1970-4. PubMed ID: 9392482
[TBL] [Abstract][Full Text] [Related]
8. Intervention therapies for insulin-dependent diabetes.
Muir A; Schatz DA; Pozzilli P; MacLaren NK
Autoimmunity; 1993; 16(4):301-10. PubMed ID: 8025209
[TBL] [Abstract][Full Text] [Related]
9. The association of MHC with autoimmune diseases: understanding the pathogenesis of autoimmune diabetes.
Ridgway WM; Fathman CG
Clin Immunol Immunopathol; 1998 Jan; 86(1):3-10. PubMed ID: 9434791
[TBL] [Abstract][Full Text] [Related]
10. Molecular aspects of HLA class II and some autoimmune diseases.
Lepage V; Lamm LU; Charron D
Eur J Immunogenet; 1993 Jun; 20(3):153-64. PubMed ID: 8338813
[No Abstract] [Full Text] [Related]
11. A new look at MHC and autoimmune disease.
Ridgway WM; Fassò M; Fathman CG
Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
[No Abstract] [Full Text] [Related]
12. Molecular mechanisms underlying diabetes and other autoimmune diseases.
Gill RG; Haskins K
Immunol Today; 1993 Feb; 14(2):49-51. PubMed ID: 8095390
[TBL] [Abstract][Full Text] [Related]
13. Autoimmunity--towards the year 2001.
Yeatman N; Sachs J; Bottazzo GF
Immunol Today; 1992 Jul; 13(7):239-40. PubMed ID: 1356343
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
15. Prevention of insulin-dependent diabetes mellitus in nonobese diabetic mice by immunogenic but not by tolerated peptides.
Vaysburd M; Lock C; McDevitt H
J Exp Med; 1995 Sep; 182(3):897-902. PubMed ID: 7650494
[TBL] [Abstract][Full Text] [Related]
16. Failure of a protective major histocompatibility complex class II molecule to delete autoreactive T cells in autoimmune diabetes.
Slattery RM; Miller JF; Heath WR; Charlton B
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10808-10. PubMed ID: 7902572
[TBL] [Abstract][Full Text] [Related]
17. IL-10 is necessary and sufficient for autoimmune diabetes in conjunction with NOD MHC homozygosity.
Lee MS; Mueller R; Wicker LS; Peterson LB; Sarvetnick N
J Exp Med; 1996 Jun; 183(6):2663-8. PubMed ID: 8676087
[TBL] [Abstract][Full Text] [Related]
18. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
19. Type I diabetes mellitus: a predictable autoimmune disease with interindividual variation in the rate of beta cell destruction.
Dotta F; Eisenbarth GS
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 2):S85-95. PubMed ID: 2642771
[TBL] [Abstract][Full Text] [Related]
20. H-2D end confers dominant protection from IL-10-mediated acceleration of autoimmune diabetes in the nonobese diabetic mouse.
La Cava A; Balasa B; Good A; van Gunst K; Jung N; Sarvetnick N
J Immunol; 2001 Jul; 167(2):1066-71. PubMed ID: 11441117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
